Finally, in the future, in order to better study the tumor microenvironment, other lymphocyte subpopulations (PD1, PD-L1, CTLA4, etc.)also need to be taken into account, to identify personalized approaches that are not only diagnostic but also therapeutic. This evidence concerns the gene CTLA4 and neoplasm.